RTI for CSIR, ICMR, and Government Research Institutions

India's publicly funded scientific research infrastructure is enormous. The Council of Scientific and Industrial Research (CSIR) alone operates 37 national laboratories spread across the country, employing tens of thousands of scientists. The Indian Council of Medical Research (ICMR) funds and conducts health research of direct consequence to hundreds of millions of people. The Indian Council of Agricultural Research (ICAR) shapes the crop varieties that farmers grow. The Department of Science and Technology (DST), the Department of Biotechnology (DBT), and the Department of Scientific and Industrial Research (DSIR) collectively disburse thousands of crores of rupees in research grants every year.

All of this activity takes place using public money, through institutions that the Right to Information Act, 2005 applies to without exception — with one significant caveat that this guide explains. If you are a researcher whose fellowship was denied, a journalist investigating a drug approval, a citizen concerned about a clinical trial conducted at a government hospital, or simply someone who wants to know how public science money is being spent, the RTI Act is your instrument.

Which Research Bodies Are Public Authorities Under Section 2(h)

The starting point is always Section 2(h) of the RTI Act, 2005, which defines a "public authority" as any authority or body established or constituted by or under a law made by Parliament or State Legislature, or owned, controlled, or substantially financed directly or indirectly by the government.

Under this definition, the following research bodies are unambiguously public authorities subject to the RTI Act:

CSIR and its 37 national laboratories. The Council of Scientific and Industrial Research is a registered society established under the Societies Registration Act, substantially funded by and under the administrative control of the Ministry of Science and Technology. All 37 CSIR labs — including CSIR-CCMB (Hyderabad), CSIR-CDRI (Lucknow), CSIR-CFTRI (Mysore), CSIR-IIP (Dehradun), CSIR-IGIB (Delhi), CSIR-IMTECH (Chandigarh), CSIR-NIO (Goa), CSIR-NCL (Pune), and CSIR-NEIST (Jorhat) — are themselves public authorities. Each lab has its own designated CPIO and First Appellate Authority.

ICMR and its constituent institutes. The Indian Council of Medical Research is an apex body for biomedical research in India, operating under the Department of Health Research, Ministry of Health and Family Welfare. ICMR's national institutes — NIMR (National Institute of Malaria Research), NIRT (National Institute for Research in Tuberculosis), NIV (National Institute of Virology), NIOH (National Institute of Occupational Health), NIRRH (National Institute for Research in Reproductive Health), and others — are public authorities. RTI applies to ICMR headquarters and to each constituent institute.

ICAR and its research institutes. The Indian Council of Agricultural Research is an autonomous organisation under the Department of Agricultural Research and Education, Ministry of Agriculture and Farmers Welfare. ICAR's network of national institutes, directorates, and project directorates — covering crops, horticulture, fisheries, animal sciences, natural resource management — are all public authorities under the RTI Act. ICAR is one of the largest agricultural research networks in the world.

DST, DBT, and DSIR. The Department of Science and Technology, the Department of Biotechnology, and the Department of Scientific and Industrial Research are government departments. As government departments, their public authority status is beyond question. The autonomous bodies and research institutes they fund — such as the S. N. Bose National Centre for Basic Sciences, the Centre for DNA Fingerprinting and Diagnostics (CDFD), the National Institute of Immunology (NII), and the Tata Institute of Fundamental Research (TIFR) — are also public authorities, as they are substantially funded by Central Government departments.

AYUSH research bodies. The Ministry of AYUSH funds and oversees several research councils covering traditional medicine systems: the Central Council for Research in Ayurvedic Sciences (CCRAS), the Central Council for Research in Unani Medicine (CCRUM), the Central Council for Research in Siddha (CCRS), the Central Council for Research in Yoga and Naturopathy (CCRYN), and the Central Council for Research in Homoeopathy (CCRH). All of these are autonomous bodies substantially funded by the Central Government and are public authorities under Section 2(h). RTI applications to them can seek research protocols, clinical trial records, grant allocation, and publication data.

Where to file and who handles the Second Appeal. All of the bodies listed above are Central Government bodies. RTI applications are filed at rtionline.gov.in. The filing fee is ₹10 under the RTI (Regulation of Fee and Cost) Rules, 2005, and is waived for BPL cardholders. The response deadline is 30 days under Section 7(1) of the RTI Act. First Appeal under Section 19(1) goes to the body's own First Appellate Authority within 30 days of the date of decision or expiry of the 30-day response period, whichever is applicable. Second Appeal goes to the Central Information Commission (CIC) under Section 19(3).

The Important Exception: DRDO and the Second Schedule

Before going any further, it is essential to flag one research institution that sits in a fundamentally different legal position from all the others discussed in this guide.

The Defence Research and Development Organisation (DRDO) is listed in the Second Schedule to the RTI Act under Section 24. Section 24 exempts organisations in the Second Schedule from the RTI Act almost entirely. The only matters that are not exempt — even for Second Schedule bodies — are allegations of corruption and human rights violations.

This is not a narrow or qualified exemption. It means that DRDO, its 50+ laboratories, and its associated establishments (DRDL, TBRL, CEMILAC, GTRE, SSPL, CAIR, and others) are, as a matter of law, largely shielded from RTI. You cannot use RTI to obtain DRDO's research grant records, project expenditure, procurement contracts, recruitment processes, or scientific outputs unless the specific information you seek relates to corruption or human rights violations.

The rationale for DRDO's exemption is clear: DRDO is India's defence technology research organisation, and its work directly concerns national security. Parliament placed it in the Second Schedule for the same reason it placed the Intelligence Bureau, RAW, and the National Technical Research Organisation there.

Citizens and journalists who want to investigate DRDO's operations face this statutory wall. RTI is simply not the mechanism for accessing DRDO records in general — unlike CSIR, ICMR, or ICAR, where RTI is fully available. This distinction is important enough to state explicitly so that you do not file RTI against DRDO expecting a general right of access that the law does not provide.

What RTI Can Access: Research Grant Allocation and Utilisation

The most significant category of information accessible through RTI at research bodies is the record of how public money is allocated and spent on research.

Grant allocation records. DST, DBT, DSIR, and ICMR disburse research grants to individual scientists (through schemes like the Ramanujan Fellowship, J. C. Bose Fellowship, Swarnajayanti Fellowship, SERB Early Career Research grant, and the DBT Ramalingaswami Fellowship) and to institutions and projects. The sanction orders for these grants, the evaluation criteria applied, and the amounts sanctioned are records held by the disbursing department and are fully accessible under RTI.

If you applied for a competitive research fellowship and were rejected, you can ask for the evaluation criteria, the minimum qualifications required, the number of applications received versus selected, and — subject to third-party privacy protections under Section 8(1)(j) — information about how your own application was assessed.

Utilisation certificates. Research grants require recipients to submit utilisation certificates periodically, certifying that funds were spent for the stated purpose. If you suspect that a grant has not been used appropriately — for example, equipment procured with a DST grant and diverted to private use — RTI can surface the utilisation certificates submitted by the grant recipient. At an ICAR institute, at a CSIR laboratory, or at an ICMR-funded project site, these documents are RTI-accessible records.

JRF and SRF selection records. Junior Research Fellowship (JRF) and Senior Research Fellowship (SRF) positions at CSIR laboratories and other research institutes are highly competitive. CSIR conducts its own NET exam for JRF, and individual institutes conduct selection for project-funded JRF and SRF posts. The selection criteria, cut-off scores, interview marks (for your own assessment), and numbers selected in each discipline are all RTI-accessible records. If you appeared for a JRF interview at a CSIR lab and believe the selection was irregular, RTI is the appropriate mechanism to examine the process.

Project expenditure statements. CSIR, ICMR, ICAR, and DST-funded institutes maintain project-level expenditure records. Budget allocations broken down by head of expenditure — equipment, consumables, travel, human resources — and the actuals spent against each head are internal accounts that RTI can reach. This information matters when investigating whether public research money is being spent efficiently.

Clinical Trial Data, Protocols, and CTRI

The Clinical Trials Registry of India (CTRI) is maintained by ICMR's National Institute of Medical Statistics (NIMS). CTRI is a public registry — it is designed to be publicly accessible, and trial registrations are visible to anyone on the CTRI website (ctri.nic.in). That is the nature of a clinical trial registry: it is a transparency instrument in itself.

RTI can extend access beyond what the CTRI portal displays. ICMR and NIMS hold records about the registration process, monitoring of ongoing trials, and compliance by trial sponsors with CTRI requirements. If a clinical trial was registered but later modified (protocol amendments are significant), you can ask for the documents submitted in support of protocol changes. If a trial appears to have not registered on time — which is a regulatory requirement — you can ask ICMR for the date of registration and the date of first enrolment.

Trial oversight and adverse event data at ICMR-funded trials. Where ICMR is itself the sponsor or co-sponsor of a clinical trial — as it was for India's Phase II and III trials for COVID-19 vaccines — the trial protocol, the safety monitoring committee's terms of reference, and aggregate adverse event data are records held by ICMR. These are not commercial research data; they are the product of publicly funded government research. RTI can seek them.

One important limitation applies here: if a clinical trial involves data about identifiable individual participants, that personal health information is protected under Section 8(1)(j) — it is personal information whose disclosure would constitute an unwarranted invasion of the participant's privacy and does not serve a legitimate public interest. The RTI request should seek aggregate data and process-level information rather than individual participant records.

Drug Approval Records at CDSCO

The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services in the Ministry of Health and Family Welfare, is the national drug regulator. CDSCO grants approval for new drugs, clinical trial permissions, and import licences. It is a public authority under the RTI Act.

RTI to CDSCO can be used to access:

• The approval date, basis for approval, and conditions attached to the approval of a specific drug marketed in India.
• The clinical data requirement waived, if any, in the approval of a new drug.
• The composition of the Subject Expert Committee (SEC) that reviewed a specific drug dossier.
• Whether a clinical trial conducted in India in support of a drug approval was properly registered with CTRI.
• Post-market surveillance data and adverse drug reactions reported to CDSCO's pharmacovigilance programme.
• Whether a manufacturing site has passed or failed CDSCO inspection.

Drug approval is an area where the tension between transparency and commercial confidentiality (discussed below) is most acute. But the process by which a public regulatory body exercises its statutory power is a public accountability matter, and RTI is the correct instrument for examining it.

Institutional Budgets, Audit Reports, and Administrative Records

Every CSIR laboratory, ICMR institute, and ICAR research institute maintains annual budgets, annual accounts, and Comptroller and Auditor General (CAG) audit reports. These are records of how public institutions have used public funds, and they are entirely accessible under RTI.

Annual reports and audit reports. Many institutes publish their annual reports proactively under Section 4 of the RTI Act, but the level of financial detail in public annual reports is often limited. RTI can seek the full trial balance, the detailed receipts and payments account, and any audit inspection report or compliance report submitted to funding departments.

Procurement records. Research institutes procure expensive equipment — electron microscopes, mass spectrometers, gene sequencers, high-performance computing clusters. Procurement at Central Government research institutes is governed by General Financial Rules and procurement manuals. RTI can surface tenders issued, bids received, technical evaluation reports, and contract awards for equipment and services procured at any CSIR, ICMR, or ICAR institute.

Recruitment and selection processes. Research institutes conduct recruitment for scientific staff (Scientist B through Scientist G or equivalent), technical staff, and administrative staff. These are public employment processes. RTI can seek the selection criteria, the number of applicants called for written test and interview, and the list of selected candidates (as a matter of public record of appointments made in public service, aggregate data is accessible). Candidates who appear for interviews and are not selected can ask for their own assessment records.

Patent filings and technology transfers. CSIR is one of India's most prolific patent-filing research organisations. CSIR's patents, licensing agreements, and technology transfer records are public institutional records. RTI can seek details of patents filed by a specific laboratory, the licensing terms for commercialised technologies, and royalty income received. This is particularly relevant given public debate about whether CSIR technologies reach industry effectively and at reasonable terms. The fact that patent claims involve technical detail does not make them commercially sensitive when it comes to disclosure of the fact and financial terms of a licensing arrangement between a public research body and an industrial licensee.

Exemptions Under Section 8(1)(d): Commercially Sensitive Research

Section 8(1)(d) of the RTI Act exempts from mandatory disclosure "information including commercial confidence, trade secrets or intellectual property, the disclosure of which would harm the competitive position of a third party, unless the competent authority is satisfied that larger public interest warrants the disclosure of such information."

This exemption is relevant but limited when applied to publicly funded research bodies. Several points of clarification matter:

Section 8(1)(d) protects third parties, not the public authority itself. If CSIR-NCL has entered into a technology licensing agreement with a private chemical company, and that agreement contains proprietary technical specifications belonging to the company, those third-party trade secrets may be withheld. But the fact of the licensing agreement, the royalty amount payable to CSIR (a public institution), and the general commercial terms are not the company's trade secrets — they are records of a public institution's commercial activities.

Research data generated using public funds does not automatically become commercially confidential. Research protocols, experimental methodologies, and scientific findings generated in a CSIR or ICMR laboratory using Central Government funding are not the kind of "commercial confidence" Section 8(1)(d) was designed to protect. The provision targets commercially sensitive information shared in confidence by a third party — a private company sharing its proprietary formulation with CDSCO for drug approval, for instance. It was not designed to allow publicly funded research institutions to withhold the results of publicly funded science.

Collaborative research with industry. Where a CSIR or DBT-funded institute conducts collaborative research with a private company, the private company's own proprietary contributions — background intellectual property, confidential data — may be protected under Section 8(1)(d). The public-funded components are not. Applicants who are aware of this distinction can frame requests more precisely: asking for the publicly funded outputs and deliverables, rather than for the industry partner's proprietary data.

Section 8(1)(a): Defence Research and National Security

Section 8(1)(a) exempts information "the disclosure of which would prejudicially affect the sovereignty and integrity of India, the security, strategic, scientific, or economic interests of the State, relation with foreign State or lead to incitement of an offence."

The phrase "scientific interests of the State" in Section 8(1)(a) has potential to be invoked broadly against research institution RTI requests. However, read correctly, Section 8(1)(a) is a causal, consequentialist test — information must be such that its disclosure would prejudicially affect those interests. It is not a general licence to withhold anything that relates to science policy.

For the research bodies discussed in this guide — CSIR, ICMR, ICAR, DST, DBT — the Section 8(1)(a) exemption has a more limited role than in the nuclear sector. The primary instances where it properly applies are:

• Research with direct defence or strategic implications: If a CSIR institute is conducting research under a classified defence programme (as distinct from DRDO, which is entirely Second Schedule-exempt), specific technical details of that programme may be withheld under Section 8(1)(a).
• Research involving foreign intelligence or diplomatic sensitivities: Scientific intelligence cooperation agreements, or information about a foreign state's scientific capabilities shared in confidence with an Indian government body, are correctly exempt.

The RTI applicant should be aware that a CPIO invoking Section 8(1)(a) to withhold, say, the budget allocation for a CSIR atmospheric chemistry project or ICMR's malaria research expenditure has significantly over-invoked the provision, and such refusals are worth challenging at First Appeal.

How Researchers Can Use RTI to Verify Published Claims

This is an underused application of RTI that is directly relevant to academic and scientific communities.

Verification of grant claims in publications. Scientific papers routinely acknowledge funding sources and grant numbers. If a paper claims to have been supported by a DST or DBT grant, RTI can verify whether that grant was actually sanctioned, for what amount, for what period, and to which institution. This is relevant in detecting ghost authorship, false acknowledgements, and fraudulent grant claims.

Checking CTRI compliance. Clinical trials conducted in India are required to be registered with CTRI before the first participant is enrolled. A researcher or journalist reviewing a published clinical trial paper can use RTI to ask ICMR/NIMS for the date on which the trial was registered, and cross-reference it against the date on which enrolment began (often stated in the paper). Retroactive registration — where a trial is registered after it has already begun or concluded — is an ethical violation that RTI can help surface.

Examining peer review records at government-funded journals. Some research journals and publications are produced by government bodies — CSIR publishes a number of journals, and ICMR publishes journals through its institutes. For these journals, editorial policies, reviewer conflicts of interest policies, and (in aggregate, not identifying individual reviewers) the number of papers reviewed versus accepted are administrative records that RTI can seek. The identity of individual peer reviewers is a different matter — that is third-party personal information with an expectation of confidentiality — but the process-level information is accessible.

Verifying institutional claims about research output. Government research institutes make public claims about the patents they have filed, the technologies they have commercialised, and the impact of their research. RTI is an instrument to verify whether the specific claims are accurate. If an institute claims to have filed 50 patents in a year, RTI can seek the patent application numbers, filing dates, and the specific technologies claimed. This keeps public institutions honest about their performance representations.

Sample RTI Questions for Research Institution Filings

The following examples illustrate well-framed RTI questions for the bodies discussed in this guide. Each should be sent via rtionline.gov.in addressed to the CPIO of the relevant institution.

To a CSIR national laboratory:

• "Please provide the number of project-funded JRF and SRF positions advertised by lab name during the period date range, the selection criteria applied, the number of candidates called for interview, and the number finally selected."
• "Please provide the total grant amount received by lab name from all Central Government funding agencies (DST, DBT, CSIR headquarters) for the financial year year, along with the project-wise breakdown and utilisation certificate status."
• "Please provide the details of technology licensing agreements concluded by lab name during year range, including the name of the licensee company, the technology licensed, and the royalty or lump-sum amount agreed."

To ICMR headquarters or a constituent institute:

• "Please provide the protocol and safety monitoring committee report for the ICMR-sponsored clinical trial registered under CTRI number registration number."
• "Please provide the aggregate number of adverse events reported to ICMR in relation to the clinical trial name/vaccine programme during period, categorised by severity grade."
• "Please provide the criteria applied for selecting ICMR research grant recipients under the scheme name programme in year, the number of applications received, and the number of grants sanctioned."

To DST or DBT:

• "Please provide the sanction letter and grant amount for the scheme name grant awarded to institution name in year, along with the latest utilisation certificate submitted by the grantee."
• "Please provide the eligibility criteria, assessment methodology, and selection committee composition used for the fellowship name fellowship awards in year."

To CDSCO:

• "Please provide the date of approval, the approval basis, and any conditions attached to the marketing authorisation granted to drug name/INN for indication, approved by CDSCO."
• "Please provide the composition of the Subject Expert Committee that reviewed the drug dossier for drug name and the date of the committee's recommendation."

To AYUSH research councils (CCRAS, CCRUM, CCRS, etc.):

• "Please provide the clinical trial protocol and registration number for the CCRAS-sponsored study on treatment/condition conducted at institute during period."
• "Please provide the total grants disbursed by CCRAS under the scheme name programme in the financial year year, along with the list of grantee institutions and grant amounts."

Filing and Appeal Process

All the research bodies discussed in this guide — CSIR and its labs, ICMR and its institutes, ICAR, DST, DBT, DSIR, CDSCO, and the AYUSH research councils — are Central Government public authorities. RTI applications are filed at rtionline.gov.in. The filing fee is ₹10 under the RTI (Regulation of Fee and Cost) Rules, 2005. BPL cardholders are exempt from the fee entirely.

Responses are due within 30 days under Section 7(1). Where the information sought concerns the life or liberty of a person, the deadline is 48 hours under the proviso to Section 7(1).

If the CPIO does not respond within 30 days, the silence is treated as a deemed refusal under Section 7(2), which triggers the right to appeal. If the response is incomplete, vague, or improperly cites an exemption, that too gives grounds for appeal.

First Appeal under Section 19(1): filed with the body's First Appellate Authority within 30 days of the date of decision or expiry of the 30-day response period, whichever is applicable. The First Appellate Authority is an officer senior to the CPIO within the same institution.

Second Appeal under Section 19(3): filed with the Central Information Commission (CIC) within 90 days of the First Appellate Authority's decision (or expiry of the time limit for it). No fee is payable for either appeal.

Penalty under Section 20: A CPIO who without reasonable cause refuses to receive an RTI application, does not provide information within the stipulated time, knowingly gives incorrect information, destroys information, or obstructs the furnishing of information may be penalised ₹250 per day up to ₹25,000, and the CIC may recommend disciplinary action. This is a meaningful personal consequence that makes the Section 20 penalty provision worth mentioning explicitly when filing a complaint about non-compliance.

One final note on the research institution context: CPIOs at CSIR laboratories and research institutes tend to be more familiar with RTI obligations than CPIOs in some other government bodies — these are educated, technically sophisticated organisations, and their administrative staff generally understand the legal framework. That does not mean all RTI applications to research bodies are easily answered; it means that a well-framed, specific request is likely to be taken seriously. Vague or sweeping requests will more often receive vague or incomplete responses. Precision is the most important attribute of a research institution RTI.

If you are a researcher, journalist, or citizen who wants to file an RTI with CSIR, ICMR, ICAR, DST, DBT, CDSCO, or another Central Government research body — and you want the application drafted precisely enough to get a substantive response — RTISathi.com can help. We draft RTI applications tailored to the specific body, the specific records you need, and the legal framework that applies to your request, including which Section 8 exemptions are likely to be invoked and how to pre-empt them.